PCSS-MOUD: More resources than you thought!

Providers Clinical Support System - Medications for Opioid Use Disorder (PCSS-MOUD), funded by the Substance Abuse and Mental Health Services Administration, offers a variety of educational resources to help clinicians improve their practices. PCSS-MOUD is a comprehensive resource for prescribers treating opioid use disorder and other substance use disorders, as well as co-occurring mental disorders. As always, everything within PCSS-MOUD is provided at no charge.

Check out what you can learn below:

PCSS-MOUD Office Hours

PCSS-MOUD Office Hours is the latest addition to our offerings, providing prescribers with access to top experts in the field. On most Fridays, a PCSS-MOUD Lead Mentor will be available for one hour via Zoom to answer your questions about treating OUD and other SUDs. Clinicians can drop by any time during the scheduled hour to get guidance and information. The office hour has been especially helpful for clinicians working in underserved and rural areas. We send out emails a few days before a session and space is limited so be sure to register if interested.

8-Hour DEA Training

PCSS-MOUD offers several ways to meet the DEA's 8-hour training requirement for new and license renewal.

• 8-Hour Education Options
• Online 8-Hour MOUD Training
• Online Nursing-Specific 8 Hour MSUD Training 
• Online 16-Hour MOUD Training
• In Person and Live Webinar Trainings

Medical Students, Trainees and Educators Resources

Historically, medical and other health professional schools have had minimal training identifying and treating substance use disorders--even though overdose deaths in the U.S. is the leading cause of accidental death.

PCSS-MOUD clinical experts have compiled a repository of educational materials that can help prepare health professionals, students and the faculty that teach them—all at no cost. PCSS-MOUD clinical experts have collected educational resources that faculty can use to develop lesson plans and curriculum for their students. Students can also independently access this free resource.

PCSS-MOUD Exchange

The next Exchange series will be held in February 2025 (more to come soon!). The intent of the course is to provide prescriber and non prescribers in a clinical setting clinicians with the basics of treating their patients with opioid use disorders with implementing medications for opioid use disorder into your clinic. This is meant to be a course to dispel myths about treating patients with medications, eliminating stigma and supporting the providers in treatment. Learn more.

PCSS-MOUD Implementation

PCSS-MOUD Implementation provides intensive and individualized implementation technical assistance to healthcare organizations and providers for the use and/or expansion of SUD and OUD.

Current implementation sites:

• A ommunity-based healthcare program in Philadelphia, PA
• A primary care clinic within a larger healthcare system in Baltimore, MD

Incoming October sites:

• A university student health clinic in Corvallis, OR
• A community mental health program in Manhattan, KS

Learn more about PCSS-MOUD Implementation.

PCSS-MOUD On-Demand Webinars

All PCSS-MOUD webinars are recorded and are available for on demand viewing, usually within two weeks of live webinar (and often sooner). Recent webinars that are now available:

Here are some recent additions to PCSS-MOUD on-demand webinars:

Clinical and Public Health Approaches to Overdose Prevention and Substance Use Care

Improving HIV and HCV Outcomes Prevention in At-Risk Rural Counties of Appalachia and the Midwest: A Social Regulation Approach

Recovery Supports for Young People with Opioid Use Disorder

Just-in-Time Smartphone Resonance Breathing for Self-management of Drug Cravings, Stress, and Anxiety

See list of all recorded webinars.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.